Measles, Mumps and Rubella (MMR) Vaccines Market - Global Outlook and Forecast 2022-2028
Measles can lead to otitis media, tracheitis, encephalitis and other complications.Mumps can cause hearing loss and inflammation of the ovaries or testes.German measles can lead to arthritis, encephalitis, conjunctivitis, miscarriage or birth defects.
This report contains market size and forecasts of Measles, Mumps and Rubella (MMR) Vaccines in global, including the following market information:
Global Measles, Mumps and Rubella (MMR) Vaccines Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Measles, Mumps and Rubella (MMR) Vaccines Market Sales, 2017-2022, 2023-2028, (K Doses)
Global top five Measles, Mumps and Rubella (MMR) Vaccines companies in 2021 (%)
The global Measles, Mumps and Rubella (MMR) Vaccines market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Monovalent Vaccine Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Measles, Mumps and Rubella (MMR) Vaccines include Medlmmune, Johnson & Johnson, Merck, Sanofi, Serum, Bavarian Nordic, Astellas Pharma, Emergent BioSolutions and GlaxoSmithKline, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Measles, Mumps and Rubella (MMR) Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Measles, Mumps and Rubella (MMR) Vaccines Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Measles, Mumps and Rubella (MMR) Vaccines Market Segment Percentages, by Type, 2021 (%)
Global Measles, Mumps and Rubella (MMR) Vaccines Market Segment Percentages, by Application, 2021 (%)
Global Measles, Mumps and Rubella (MMR) Vaccines Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Measles, Mumps and Rubella (MMR) Vaccines revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Measles, Mumps and Rubella (MMR) Vaccines revenues share in global market, 2021 (%)
Key companies Measles, Mumps and Rubella (MMR) Vaccines sales in global market, 2017-2022 (Estimated), (K Doses)
Key companies Measles, Mumps and Rubella (MMR) Vaccines sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Measles, Mumps and Rubella (MMR) Vaccines in global, including the following market information:
Global Measles, Mumps and Rubella (MMR) Vaccines Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Measles, Mumps and Rubella (MMR) Vaccines Market Sales, 2017-2022, 2023-2028, (K Doses)
Global top five Measles, Mumps and Rubella (MMR) Vaccines companies in 2021 (%)
The global Measles, Mumps and Rubella (MMR) Vaccines market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Monovalent Vaccine Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Measles, Mumps and Rubella (MMR) Vaccines include Medlmmune, Johnson & Johnson, Merck, Sanofi, Serum, Bavarian Nordic, Astellas Pharma, Emergent BioSolutions and GlaxoSmithKline, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Measles, Mumps and Rubella (MMR) Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Measles, Mumps and Rubella (MMR) Vaccines Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Measles, Mumps and Rubella (MMR) Vaccines Market Segment Percentages, by Type, 2021 (%)
- Monovalent Vaccine
- Polyvalent Vaccine
Global Measles, Mumps and Rubella (MMR) Vaccines Market Segment Percentages, by Application, 2021 (%)
- Immune Center
- Vaccine Development Agencies and Organizations
- Hospital
- Laboratory
- Biotechnology and Biopharmaceutical Companies
Global Measles, Mumps and Rubella (MMR) Vaccines Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Measles, Mumps and Rubella (MMR) Vaccines revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Measles, Mumps and Rubella (MMR) Vaccines revenues share in global market, 2021 (%)
Key companies Measles, Mumps and Rubella (MMR) Vaccines sales in global market, 2017-2022 (Estimated), (K Doses)
Key companies Measles, Mumps and Rubella (MMR) Vaccines sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Medlmmune
- Johnson & Johnson
- Merck
- Sanofi
- Serum
- Bavarian Nordic
- Astellas Pharma
- Emergent BioSolutions
- GlaxoSmithKline
- Pfizer
- CSL
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Measles, Mumps and Rubella (MMR) Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Measles, Mumps and Rubella (MMR) Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL MEASLES, MUMPS AND RUBELLA (MMR) VACCINES OVERALL MARKET SIZE
2.1 Global Measles, Mumps and Rubella (MMR) Vaccines Market Size: 2021 VS 2028
2.2 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Measles, Mumps and Rubella (MMR) Vaccines Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Measles, Mumps and Rubella (MMR) Vaccines Players in Global Market
3.2 Top Global Measles, Mumps and Rubella (MMR) Vaccines Companies Ranked by Revenue
3.3 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue by Companies
3.4 Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Companies
3.5 Global Measles, Mumps and Rubella (MMR) Vaccines Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Measles, Mumps and Rubella (MMR) Vaccines Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Measles, Mumps and Rubella (MMR) Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Measles, Mumps and Rubella (MMR) Vaccines Players in Global Market
3.8.1 List of Global Tier 1 Measles, Mumps and Rubella (MMR) Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 Measles, Mumps and Rubella (MMR) Vaccines Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Measles, Mumps and Rubella (MMR) Vaccines Market Size Markets, 2021 & 2028
4.1.2 Monovalent Vaccine
4.1.3 Polyvalent Vaccine
4.2 By Type - Global Measles, Mumps and Rubella (MMR) Vaccines Revenue & Forecasts
4.2.1 By Type - Global Measles, Mumps and Rubella (MMR) Vaccines Revenue, 2017-2022
4.2.2 By Type - Global Measles, Mumps and Rubella (MMR) Vaccines Revenue, 2023-2028
4.2.3 By Type - Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share, 2017-2028
4.3 By Type - Global Measles, Mumps and Rubella (MMR) Vaccines Sales & Forecasts
4.3.1 By Type - Global Measles, Mumps and Rubella (MMR) Vaccines Sales, 2017-2022
4.3.2 By Type - Global Measles, Mumps and Rubella (MMR) Vaccines Sales, 2023-2028
4.3.3 By Type - Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share, 2017-2028
4.4 By Type - Global Measles, Mumps and Rubella (MMR) Vaccines Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2021 & 2028
5.1.2 Immune Center
5.1.3 Vaccine Development Agencies and Organizations
5.1.4 Hospital
5.1.5 Laboratory
5.1.6 Biotechnology and Biopharmaceutical Companies
5.2 By Application - Global Measles, Mumps and Rubella (MMR) Vaccines Revenue & Forecasts
5.2.1 By Application - Global Measles, Mumps and Rubella (MMR) Vaccines Revenue, 2017-2022
5.2.2 By Application - Global Measles, Mumps and Rubella (MMR) Vaccines Revenue, 2023-2028
5.2.3 By Application - Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share, 2017-2028
5.3 By Application - Global Measles, Mumps and Rubella (MMR) Vaccines Sales & Forecasts
5.3.1 By Application - Global Measles, Mumps and Rubella (MMR) Vaccines Sales, 2017-2022
5.3.2 By Application - Global Measles, Mumps and Rubella (MMR) Vaccines Sales, 2023-2028
5.3.3 By Application - Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share, 2017-2028
5.4 By Application - Global Measles, Mumps and Rubella (MMR) Vaccines Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2021 & 2028
6.2 By Region - Global Measles, Mumps and Rubella (MMR) Vaccines Revenue & Forecasts
6.2.1 By Region - Global Measles, Mumps and Rubella (MMR) Vaccines Revenue, 2017-2022
6.2.2 By Region - Global Measles, Mumps and Rubella (MMR) Vaccines Revenue, 2023-2028
6.2.3 By Region - Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share, 2017-2028
6.3 By Region - Global Measles, Mumps and Rubella (MMR) Vaccines Sales & Forecasts
6.3.1 By Region - Global Measles, Mumps and Rubella (MMR) Vaccines Sales, 2017-2022
6.3.2 By Region - Global Measles, Mumps and Rubella (MMR) Vaccines Sales, 2023-2028
6.3.3 By Region - Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Measles, Mumps and Rubella (MMR) Vaccines Revenue, 2017-2028
6.4.2 By Country - North America Measles, Mumps and Rubella (MMR) Vaccines Sales, 2017-2028
6.4.3 US Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2017-2028
6.4.4 Canada Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2017-2028
6.4.5 Mexico Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue, 2017-2028
6.5.2 By Country - Europe Measles, Mumps and Rubella (MMR) Vaccines Sales, 2017-2028
6.5.3 Germany Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2017-2028
6.5.4 France Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2017-2028
6.5.5 U.K. Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2017-2028
6.5.6 Italy Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2017-2028
6.5.7 Russia Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2017-2028
6.5.8 Nordic Countries Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2017-2028
6.5.9 Benelux Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Measles, Mumps and Rubella (MMR) Vaccines Revenue, 2017-2028
6.6.2 By Region - Asia Measles, Mumps and Rubella (MMR) Vaccines Sales, 2017-2028
6.6.3 China Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2017-2028
6.6.4 Japan Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2017-2028
6.6.5 South Korea Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2017-2028
6.6.6 Southeast Asia Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2017-2028
6.6.7 India Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Measles, Mumps and Rubella (MMR) Vaccines Revenue, 2017-2028
6.7.2 By Country - South America Measles, Mumps and Rubella (MMR) Vaccines Sales, 2017-2028
6.7.3 Brazil Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2017-2028
6.7.4 Argentina Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Measles, Mumps and Rubella (MMR) Vaccines Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Measles, Mumps and Rubella (MMR) Vaccines Sales, 2017-2028
6.8.3 Turkey Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2017-2028
6.8.4 Israel Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2017-2028
6.8.5 Saudi Arabia Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2017-2028
6.8.6 UAE Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Medlmmune
7.1.1 Medlmmune Corporate Summary
7.1.2 Medlmmune Business Overview
7.1.3 Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Major Product Offerings
7.1.4 Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Sales and Revenue in Global (2017-2022)
7.1.5 Medlmmune Key News
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Corporate Summary
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson Measles, Mumps and Rubella (MMR) Vaccines Major Product Offerings
7.2.4 Johnson & Johnson Measles, Mumps and Rubella (MMR) Vaccines Sales and Revenue in Global (2017-2022)
7.2.5 Johnson & Johnson Key News
7.3 Merck
7.3.1 Merck Corporate Summary
7.3.2 Merck Business Overview
7.3.3 Merck Measles, Mumps and Rubella (MMR) Vaccines Major Product Offerings
7.3.4 Merck Measles, Mumps and Rubella (MMR) Vaccines Sales and Revenue in Global (2017-2022)
7.3.5 Merck Key News
7.4 Sanofi
7.4.1 Sanofi Corporate Summary
7.4.2 Sanofi Business Overview
7.4.3 Sanofi Measles, Mumps and Rubella (MMR) Vaccines Major Product Offerings
7.4.4 Sanofi Measles, Mumps and Rubella (MMR) Vaccines Sales and Revenue in Global (2017-2022)
7.4.5 Sanofi Key News
7.5 Serum
7.5.1 Serum Corporate Summary
7.5.2 Serum Business Overview
7.5.3 Serum Measles, Mumps and Rubella (MMR) Vaccines Major Product Offerings
7.5.4 Serum Measles, Mumps and Rubella (MMR) Vaccines Sales and Revenue in Global (2017-2022)
7.5.5 Serum Key News
7.6 Bavarian Nordic
7.6.1 Bavarian Nordic Corporate Summary
7.6.2 Bavarian Nordic Business Overview
7.6.3 Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Major Product Offerings
7.6.4 Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Sales and Revenue in Global (2017-2022)
7.6.5 Bavarian Nordic Key News
7.7 Astellas Pharma
7.7.1 Astellas Pharma Corporate Summary
7.7.2 Astellas Pharma Business Overview
7.7.3 Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Major Product Offerings
7.7.4 Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Sales and Revenue in Global (2017-2022)
7.7.5 Astellas Pharma Key News
7.8 Emergent BioSolutions
7.8.1 Emergent BioSolutions Corporate Summary
7.8.2 Emergent BioSolutions Business Overview
7.8.3 Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Major Product Offerings
7.8.4 Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Sales and Revenue in Global (2017-2022)
7.8.5 Emergent BioSolutions Key News
7.9 GlaxoSmithKline
7.9.1 GlaxoSmithKline Corporate Summary
7.9.2 GlaxoSmithKline Business Overview
7.9.3 GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Major Product Offerings
7.9.4 GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Sales and Revenue in Global (2017-2022)
7.9.5 GlaxoSmithKline Key News
7.10 Pfizer
7.10.1 Pfizer Corporate Summary
7.10.2 Pfizer Business Overview
7.10.3 Pfizer Measles, Mumps and Rubella (MMR) Vaccines Major Product Offerings
7.10.4 Pfizer Measles, Mumps and Rubella (MMR) Vaccines Sales and Revenue in Global (2017-2022)
7.10.5 Pfizer Key News
7.11 CSL
7.11.1 CSL Corporate Summary
7.11.2 CSL Measles, Mumps and Rubella (MMR) Vaccines Business Overview
7.11.3 CSL Measles, Mumps and Rubella (MMR) Vaccines Major Product Offerings
7.11.4 CSL Measles, Mumps and Rubella (MMR) Vaccines Sales and Revenue in Global (2017-2022)
7.11.5 CSL Key News
8 GLOBAL MEASLES, MUMPS AND RUBELLA (MMR) VACCINES PRODUCTION CAPACITY, ANALYSIS
8.1 Global Measles, Mumps and Rubella (MMR) Vaccines Production Capacity, 2017-2028
8.2 Measles, Mumps and Rubella (MMR) Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Measles, Mumps and Rubella (MMR) Vaccines Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 MEASLES, MUMPS AND RUBELLA (MMR) VACCINES SUPPLY CHAIN ANALYSIS
10.1 Measles, Mumps and Rubella (MMR) Vaccines Industry Value Chain
10.2 Measles, Mumps and Rubella (MMR) Vaccines Upstream Market
10.3 Measles, Mumps and Rubella (MMR) Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Measles, Mumps and Rubella (MMR) Vaccines Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Measles, Mumps and Rubella (MMR) Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Measles, Mumps and Rubella (MMR) Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL MEASLES, MUMPS AND RUBELLA (MMR) VACCINES OVERALL MARKET SIZE
2.1 Global Measles, Mumps and Rubella (MMR) Vaccines Market Size: 2021 VS 2028
2.2 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Measles, Mumps and Rubella (MMR) Vaccines Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Measles, Mumps and Rubella (MMR) Vaccines Players in Global Market
3.2 Top Global Measles, Mumps and Rubella (MMR) Vaccines Companies Ranked by Revenue
3.3 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue by Companies
3.4 Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Companies
3.5 Global Measles, Mumps and Rubella (MMR) Vaccines Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Measles, Mumps and Rubella (MMR) Vaccines Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Measles, Mumps and Rubella (MMR) Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Measles, Mumps and Rubella (MMR) Vaccines Players in Global Market
3.8.1 List of Global Tier 1 Measles, Mumps and Rubella (MMR) Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 Measles, Mumps and Rubella (MMR) Vaccines Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Measles, Mumps and Rubella (MMR) Vaccines Market Size Markets, 2021 & 2028
4.1.2 Monovalent Vaccine
4.1.3 Polyvalent Vaccine
4.2 By Type - Global Measles, Mumps and Rubella (MMR) Vaccines Revenue & Forecasts
4.2.1 By Type - Global Measles, Mumps and Rubella (MMR) Vaccines Revenue, 2017-2022
4.2.2 By Type - Global Measles, Mumps and Rubella (MMR) Vaccines Revenue, 2023-2028
4.2.3 By Type - Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share, 2017-2028
4.3 By Type - Global Measles, Mumps and Rubella (MMR) Vaccines Sales & Forecasts
4.3.1 By Type - Global Measles, Mumps and Rubella (MMR) Vaccines Sales, 2017-2022
4.3.2 By Type - Global Measles, Mumps and Rubella (MMR) Vaccines Sales, 2023-2028
4.3.3 By Type - Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share, 2017-2028
4.4 By Type - Global Measles, Mumps and Rubella (MMR) Vaccines Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2021 & 2028
5.1.2 Immune Center
5.1.3 Vaccine Development Agencies and Organizations
5.1.4 Hospital
5.1.5 Laboratory
5.1.6 Biotechnology and Biopharmaceutical Companies
5.2 By Application - Global Measles, Mumps and Rubella (MMR) Vaccines Revenue & Forecasts
5.2.1 By Application - Global Measles, Mumps and Rubella (MMR) Vaccines Revenue, 2017-2022
5.2.2 By Application - Global Measles, Mumps and Rubella (MMR) Vaccines Revenue, 2023-2028
5.2.3 By Application - Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share, 2017-2028
5.3 By Application - Global Measles, Mumps and Rubella (MMR) Vaccines Sales & Forecasts
5.3.1 By Application - Global Measles, Mumps and Rubella (MMR) Vaccines Sales, 2017-2022
5.3.2 By Application - Global Measles, Mumps and Rubella (MMR) Vaccines Sales, 2023-2028
5.3.3 By Application - Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share, 2017-2028
5.4 By Application - Global Measles, Mumps and Rubella (MMR) Vaccines Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2021 & 2028
6.2 By Region - Global Measles, Mumps and Rubella (MMR) Vaccines Revenue & Forecasts
6.2.1 By Region - Global Measles, Mumps and Rubella (MMR) Vaccines Revenue, 2017-2022
6.2.2 By Region - Global Measles, Mumps and Rubella (MMR) Vaccines Revenue, 2023-2028
6.2.3 By Region - Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share, 2017-2028
6.3 By Region - Global Measles, Mumps and Rubella (MMR) Vaccines Sales & Forecasts
6.3.1 By Region - Global Measles, Mumps and Rubella (MMR) Vaccines Sales, 2017-2022
6.3.2 By Region - Global Measles, Mumps and Rubella (MMR) Vaccines Sales, 2023-2028
6.3.3 By Region - Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Measles, Mumps and Rubella (MMR) Vaccines Revenue, 2017-2028
6.4.2 By Country - North America Measles, Mumps and Rubella (MMR) Vaccines Sales, 2017-2028
6.4.3 US Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2017-2028
6.4.4 Canada Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2017-2028
6.4.5 Mexico Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue, 2017-2028
6.5.2 By Country - Europe Measles, Mumps and Rubella (MMR) Vaccines Sales, 2017-2028
6.5.3 Germany Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2017-2028
6.5.4 France Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2017-2028
6.5.5 U.K. Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2017-2028
6.5.6 Italy Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2017-2028
6.5.7 Russia Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2017-2028
6.5.8 Nordic Countries Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2017-2028
6.5.9 Benelux Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Measles, Mumps and Rubella (MMR) Vaccines Revenue, 2017-2028
6.6.2 By Region - Asia Measles, Mumps and Rubella (MMR) Vaccines Sales, 2017-2028
6.6.3 China Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2017-2028
6.6.4 Japan Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2017-2028
6.6.5 South Korea Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2017-2028
6.6.6 Southeast Asia Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2017-2028
6.6.7 India Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Measles, Mumps and Rubella (MMR) Vaccines Revenue, 2017-2028
6.7.2 By Country - South America Measles, Mumps and Rubella (MMR) Vaccines Sales, 2017-2028
6.7.3 Brazil Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2017-2028
6.7.4 Argentina Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Measles, Mumps and Rubella (MMR) Vaccines Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Measles, Mumps and Rubella (MMR) Vaccines Sales, 2017-2028
6.8.3 Turkey Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2017-2028
6.8.4 Israel Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2017-2028
6.8.5 Saudi Arabia Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2017-2028
6.8.6 UAE Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Medlmmune
7.1.1 Medlmmune Corporate Summary
7.1.2 Medlmmune Business Overview
7.1.3 Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Major Product Offerings
7.1.4 Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Sales and Revenue in Global (2017-2022)
7.1.5 Medlmmune Key News
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Corporate Summary
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson Measles, Mumps and Rubella (MMR) Vaccines Major Product Offerings
7.2.4 Johnson & Johnson Measles, Mumps and Rubella (MMR) Vaccines Sales and Revenue in Global (2017-2022)
7.2.5 Johnson & Johnson Key News
7.3 Merck
7.3.1 Merck Corporate Summary
7.3.2 Merck Business Overview
7.3.3 Merck Measles, Mumps and Rubella (MMR) Vaccines Major Product Offerings
7.3.4 Merck Measles, Mumps and Rubella (MMR) Vaccines Sales and Revenue in Global (2017-2022)
7.3.5 Merck Key News
7.4 Sanofi
7.4.1 Sanofi Corporate Summary
7.4.2 Sanofi Business Overview
7.4.3 Sanofi Measles, Mumps and Rubella (MMR) Vaccines Major Product Offerings
7.4.4 Sanofi Measles, Mumps and Rubella (MMR) Vaccines Sales and Revenue in Global (2017-2022)
7.4.5 Sanofi Key News
7.5 Serum
7.5.1 Serum Corporate Summary
7.5.2 Serum Business Overview
7.5.3 Serum Measles, Mumps and Rubella (MMR) Vaccines Major Product Offerings
7.5.4 Serum Measles, Mumps and Rubella (MMR) Vaccines Sales and Revenue in Global (2017-2022)
7.5.5 Serum Key News
7.6 Bavarian Nordic
7.6.1 Bavarian Nordic Corporate Summary
7.6.2 Bavarian Nordic Business Overview
7.6.3 Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Major Product Offerings
7.6.4 Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Sales and Revenue in Global (2017-2022)
7.6.5 Bavarian Nordic Key News
7.7 Astellas Pharma
7.7.1 Astellas Pharma Corporate Summary
7.7.2 Astellas Pharma Business Overview
7.7.3 Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Major Product Offerings
7.7.4 Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Sales and Revenue in Global (2017-2022)
7.7.5 Astellas Pharma Key News
7.8 Emergent BioSolutions
7.8.1 Emergent BioSolutions Corporate Summary
7.8.2 Emergent BioSolutions Business Overview
7.8.3 Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Major Product Offerings
7.8.4 Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Sales and Revenue in Global (2017-2022)
7.8.5 Emergent BioSolutions Key News
7.9 GlaxoSmithKline
7.9.1 GlaxoSmithKline Corporate Summary
7.9.2 GlaxoSmithKline Business Overview
7.9.3 GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Major Product Offerings
7.9.4 GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Sales and Revenue in Global (2017-2022)
7.9.5 GlaxoSmithKline Key News
7.10 Pfizer
7.10.1 Pfizer Corporate Summary
7.10.2 Pfizer Business Overview
7.10.3 Pfizer Measles, Mumps and Rubella (MMR) Vaccines Major Product Offerings
7.10.4 Pfizer Measles, Mumps and Rubella (MMR) Vaccines Sales and Revenue in Global (2017-2022)
7.10.5 Pfizer Key News
7.11 CSL
7.11.1 CSL Corporate Summary
7.11.2 CSL Measles, Mumps and Rubella (MMR) Vaccines Business Overview
7.11.3 CSL Measles, Mumps and Rubella (MMR) Vaccines Major Product Offerings
7.11.4 CSL Measles, Mumps and Rubella (MMR) Vaccines Sales and Revenue in Global (2017-2022)
7.11.5 CSL Key News
8 GLOBAL MEASLES, MUMPS AND RUBELLA (MMR) VACCINES PRODUCTION CAPACITY, ANALYSIS
8.1 Global Measles, Mumps and Rubella (MMR) Vaccines Production Capacity, 2017-2028
8.2 Measles, Mumps and Rubella (MMR) Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Measles, Mumps and Rubella (MMR) Vaccines Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 MEASLES, MUMPS AND RUBELLA (MMR) VACCINES SUPPLY CHAIN ANALYSIS
10.1 Measles, Mumps and Rubella (MMR) Vaccines Industry Value Chain
10.2 Measles, Mumps and Rubella (MMR) Vaccines Upstream Market
10.3 Measles, Mumps and Rubella (MMR) Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Measles, Mumps and Rubella (MMR) Vaccines Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Measles, Mumps and Rubella (MMR) Vaccines in Global Market
Table 2. Top Measles, Mumps and Rubella (MMR) Vaccines Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Share by Companies, 2017-2022
Table 5. Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Companies, (K Doses), 2017-2022
Table 6. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Measles, Mumps and Rubella (MMR) Vaccines Price (2017-2022) & (USD/Dose)
Table 8. Global Manufacturers Measles, Mumps and Rubella (MMR) Vaccines Product Type
Table 9. List of Global Tier 1 Measles, Mumps and Rubella (MMR) Vaccines Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Measles, Mumps and Rubella (MMR) Vaccines Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Measles, Mumps and Rubella (MMR) Vaccines Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Measles, Mumps and Rubella (MMR) Vaccines Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), 2017-2022
Table 15. By Type - Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), 2023-2028
Table 16. By Application – Global Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Measles, Mumps and Rubella (MMR) Vaccines Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Measles, Mumps and Rubella (MMR) Vaccines Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), 2017-2022
Table 20. By Application - Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), 2023-2028
Table 21. By Region – Global Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Measles, Mumps and Rubella (MMR) Vaccines Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Measles, Mumps and Rubella (MMR) Vaccines Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), 2017-2022
Table 25. By Region - Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), 2023-2028
Table 26. By Country - North America Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Measles, Mumps and Rubella (MMR) Vaccines Sales, (K Doses), 2017-2022
Table 29. By Country - North America Measles, Mumps and Rubella (MMR) Vaccines Sales, (K Doses), 2023-2028
Table 30. By Country - Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Measles, Mumps and Rubella (MMR) Vaccines Sales, (K Doses), 2017-2022
Table 33. By Country - Europe Measles, Mumps and Rubella (MMR) Vaccines Sales, (K Doses), 2023-2028
Table 34. By Region - Asia Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Measles, Mumps and Rubella (MMR) Vaccines Sales, (K Doses), 2017-2022
Table 37. By Region - Asia Measles, Mumps and Rubella (MMR) Vaccines Sales, (K Doses), 2023-2028
Table 38. By Country - South America Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Measles, Mumps and Rubella (MMR) Vaccines Sales, (K Doses), 2017-2022
Table 41. By Country - South America Measles, Mumps and Rubella (MMR) Vaccines Sales, (K Doses), 2023-2028
Table 42. By Country - Middle East & Africa Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Measles, Mumps and Rubella (MMR) Vaccines Sales, (K Doses), 2017-2022
Table 45. By Country - Middle East & Africa Measles, Mumps and Rubella (MMR) Vaccines Sales, (K Doses), 2023-2028
Table 46. Medlmmune Corporate Summary
Table 47. Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Product Offerings
Table 48. Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 49. Johnson & Johnson Corporate Summary
Table 50. Johnson & Johnson Measles, Mumps and Rubella (MMR) Vaccines Product Offerings
Table 51. Johnson & Johnson Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 52. Merck Corporate Summary
Table 53. Merck Measles, Mumps and Rubella (MMR) Vaccines Product Offerings
Table 54. Merck Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 55. Sanofi Corporate Summary
Table 56. Sanofi Measles, Mumps and Rubella (MMR) Vaccines Product Offerings
Table 57. Sanofi Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 58. Serum Corporate Summary
Table 59. Serum Measles, Mumps and Rubella (MMR) Vaccines Product Offerings
Table 60. Serum Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 61. Bavarian Nordic Corporate Summary
Table 62. Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Product Offerings
Table 63. Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 64. Astellas Pharma Corporate Summary
Table 65. Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Product Offerings
Table 66. Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 67. Emergent BioSolutions Corporate Summary
Table 68. Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Product Offerings
Table 69. Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 70. GlaxoSmithKline Corporate Summary
Table 71. GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Product Offerings
Table 72. GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 73. Pfizer Corporate Summary
Table 74. Pfizer Measles, Mumps and Rubella (MMR) Vaccines Product Offerings
Table 75. Pfizer Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 76. CSL Corporate Summary
Table 77. CSL Measles, Mumps and Rubella (MMR) Vaccines Product Offerings
Table 78. CSL Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 79. Measles, Mumps and Rubella (MMR) Vaccines Production Capacity (K Doses) of Key Manufacturers in Global Market, 2020-2022 (K Doses)
Table 80. Global Measles, Mumps and Rubella (MMR) Vaccines Capacity Market Share of Key Manufacturers, 2020-2022
Table 81. Global Measles, Mumps and Rubella (MMR) Vaccines Production by Region, 2017-2022 (K Doses)
Table 82. Global Measles, Mumps and Rubella (MMR) Vaccines Production by Region, 2023-2028 (K Doses)
Table 83. Measles, Mumps and Rubella (MMR) Vaccines Market Opportunities & Trends in Global Market
Table 84. Measles, Mumps and Rubella (MMR) Vaccines Market Drivers in Global Market
Table 85. Measles, Mumps and Rubella (MMR) Vaccines Market Restraints in Global Market
Table 86. Measles, Mumps and Rubella (MMR) Vaccines Raw Materials
Table 87. Measles, Mumps and Rubella (MMR) Vaccines Raw Materials Suppliers in Global Market
Table 88. Typical Measles, Mumps and Rubella (MMR) Vaccines Downstream
Table 89. Measles, Mumps and Rubella (MMR) Vaccines Downstream Clients in Global Market
Table 90. Measles, Mumps and Rubella (MMR) Vaccines Distributors and Sales Agents in Global Market
Table 1. Key Players of Measles, Mumps and Rubella (MMR) Vaccines in Global Market
Table 2. Top Measles, Mumps and Rubella (MMR) Vaccines Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Share by Companies, 2017-2022
Table 5. Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Companies, (K Doses), 2017-2022
Table 6. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Measles, Mumps and Rubella (MMR) Vaccines Price (2017-2022) & (USD/Dose)
Table 8. Global Manufacturers Measles, Mumps and Rubella (MMR) Vaccines Product Type
Table 9. List of Global Tier 1 Measles, Mumps and Rubella (MMR) Vaccines Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Measles, Mumps and Rubella (MMR) Vaccines Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Measles, Mumps and Rubella (MMR) Vaccines Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Measles, Mumps and Rubella (MMR) Vaccines Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), 2017-2022
Table 15. By Type - Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), 2023-2028
Table 16. By Application – Global Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Measles, Mumps and Rubella (MMR) Vaccines Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Measles, Mumps and Rubella (MMR) Vaccines Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), 2017-2022
Table 20. By Application - Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), 2023-2028
Table 21. By Region – Global Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Measles, Mumps and Rubella (MMR) Vaccines Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Measles, Mumps and Rubella (MMR) Vaccines Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), 2017-2022
Table 25. By Region - Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), 2023-2028
Table 26. By Country - North America Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Measles, Mumps and Rubella (MMR) Vaccines Sales, (K Doses), 2017-2022
Table 29. By Country - North America Measles, Mumps and Rubella (MMR) Vaccines Sales, (K Doses), 2023-2028
Table 30. By Country - Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Measles, Mumps and Rubella (MMR) Vaccines Sales, (K Doses), 2017-2022
Table 33. By Country - Europe Measles, Mumps and Rubella (MMR) Vaccines Sales, (K Doses), 2023-2028
Table 34. By Region - Asia Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Measles, Mumps and Rubella (MMR) Vaccines Sales, (K Doses), 2017-2022
Table 37. By Region - Asia Measles, Mumps and Rubella (MMR) Vaccines Sales, (K Doses), 2023-2028
Table 38. By Country - South America Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Measles, Mumps and Rubella (MMR) Vaccines Sales, (K Doses), 2017-2022
Table 41. By Country - South America Measles, Mumps and Rubella (MMR) Vaccines Sales, (K Doses), 2023-2028
Table 42. By Country - Middle East & Africa Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Measles, Mumps and Rubella (MMR) Vaccines Sales, (K Doses), 2017-2022
Table 45. By Country - Middle East & Africa Measles, Mumps and Rubella (MMR) Vaccines Sales, (K Doses), 2023-2028
Table 46. Medlmmune Corporate Summary
Table 47. Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Product Offerings
Table 48. Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 49. Johnson & Johnson Corporate Summary
Table 50. Johnson & Johnson Measles, Mumps and Rubella (MMR) Vaccines Product Offerings
Table 51. Johnson & Johnson Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 52. Merck Corporate Summary
Table 53. Merck Measles, Mumps and Rubella (MMR) Vaccines Product Offerings
Table 54. Merck Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 55. Sanofi Corporate Summary
Table 56. Sanofi Measles, Mumps and Rubella (MMR) Vaccines Product Offerings
Table 57. Sanofi Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 58. Serum Corporate Summary
Table 59. Serum Measles, Mumps and Rubella (MMR) Vaccines Product Offerings
Table 60. Serum Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 61. Bavarian Nordic Corporate Summary
Table 62. Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Product Offerings
Table 63. Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 64. Astellas Pharma Corporate Summary
Table 65. Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Product Offerings
Table 66. Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 67. Emergent BioSolutions Corporate Summary
Table 68. Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Product Offerings
Table 69. Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 70. GlaxoSmithKline Corporate Summary
Table 71. GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Product Offerings
Table 72. GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 73. Pfizer Corporate Summary
Table 74. Pfizer Measles, Mumps and Rubella (MMR) Vaccines Product Offerings
Table 75. Pfizer Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 76. CSL Corporate Summary
Table 77. CSL Measles, Mumps and Rubella (MMR) Vaccines Product Offerings
Table 78. CSL Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 79. Measles, Mumps and Rubella (MMR) Vaccines Production Capacity (K Doses) of Key Manufacturers in Global Market, 2020-2022 (K Doses)
Table 80. Global Measles, Mumps and Rubella (MMR) Vaccines Capacity Market Share of Key Manufacturers, 2020-2022
Table 81. Global Measles, Mumps and Rubella (MMR) Vaccines Production by Region, 2017-2022 (K Doses)
Table 82. Global Measles, Mumps and Rubella (MMR) Vaccines Production by Region, 2023-2028 (K Doses)
Table 83. Measles, Mumps and Rubella (MMR) Vaccines Market Opportunities & Trends in Global Market
Table 84. Measles, Mumps and Rubella (MMR) Vaccines Market Drivers in Global Market
Table 85. Measles, Mumps and Rubella (MMR) Vaccines Market Restraints in Global Market
Table 86. Measles, Mumps and Rubella (MMR) Vaccines Raw Materials
Table 87. Measles, Mumps and Rubella (MMR) Vaccines Raw Materials Suppliers in Global Market
Table 88. Typical Measles, Mumps and Rubella (MMR) Vaccines Downstream
Table 89. Measles, Mumps and Rubella (MMR) Vaccines Downstream Clients in Global Market
Table 90. Measles, Mumps and Rubella (MMR) Vaccines Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Measles, Mumps and Rubella (MMR) Vaccines Segment by Type
Figure 2. Measles, Mumps and Rubella (MMR) Vaccines Segment by Application
Figure 3. Global Measles, Mumps and Rubella (MMR) Vaccines Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Measles, Mumps and Rubella (MMR) Vaccines Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue, 2017-2028 (US$, Mn)
Figure 7. Measles, Mumps and Rubella (MMR) Vaccines Sales in Global Market: 2017-2028 (K Doses)
Figure 8. The Top 3 and 5 Players Market Share by Measles, Mumps and Rubella (MMR) Vaccines Revenue in 2021
Figure 9. By Type - Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share, 2017-2028
Figure 10. By Type - Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share, 2017-2028
Figure 11. By Type - Global Measles, Mumps and Rubella (MMR) Vaccines Price (USD/Dose), 2017-2028
Figure 12. By Application - Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share, 2017-2028
Figure 13. By Application - Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share, 2017-2028
Figure 14. By Application - Global Measles, Mumps and Rubella (MMR) Vaccines Price (USD/Dose), 2017-2028
Figure 15. By Region - Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share, 2017-2028
Figure 16. By Region - Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share, 2017-2028
Figure 17. By Country - North America Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share, 2017-2028
Figure 18. By Country - North America Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share, 2017-2028
Figure 19. US Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share, 2017-2028
Figure 24. Germany Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2017-2028
Figure 25. France Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share, 2017-2028
Figure 33. China Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2017-2028
Figure 37. India Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share, 2017-2028
Figure 39. By Country - South America Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share, 2017-2028
Figure 40. Brazil Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share, 2017-2028
Figure 44. Turkey Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2017-2028
Figure 48. Global Measles, Mumps and Rubella (MMR) Vaccines Production Capacity (K Doses), 2017-2028
Figure 49. The Percentage of Production Measles, Mumps and Rubella (MMR) Vaccines by Region, 2021 VS 2028
Figure 50. Measles, Mumps and Rubella (MMR) Vaccines Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Measles, Mumps and Rubella (MMR) Vaccines Segment by Type
Figure 2. Measles, Mumps and Rubella (MMR) Vaccines Segment by Application
Figure 3. Global Measles, Mumps and Rubella (MMR) Vaccines Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Measles, Mumps and Rubella (MMR) Vaccines Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue, 2017-2028 (US$, Mn)
Figure 7. Measles, Mumps and Rubella (MMR) Vaccines Sales in Global Market: 2017-2028 (K Doses)
Figure 8. The Top 3 and 5 Players Market Share by Measles, Mumps and Rubella (MMR) Vaccines Revenue in 2021
Figure 9. By Type - Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share, 2017-2028
Figure 10. By Type - Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share, 2017-2028
Figure 11. By Type - Global Measles, Mumps and Rubella (MMR) Vaccines Price (USD/Dose), 2017-2028
Figure 12. By Application - Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share, 2017-2028
Figure 13. By Application - Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share, 2017-2028
Figure 14. By Application - Global Measles, Mumps and Rubella (MMR) Vaccines Price (USD/Dose), 2017-2028
Figure 15. By Region - Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share, 2017-2028
Figure 16. By Region - Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share, 2017-2028
Figure 17. By Country - North America Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share, 2017-2028
Figure 18. By Country - North America Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share, 2017-2028
Figure 19. US Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share, 2017-2028
Figure 24. Germany Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2017-2028
Figure 25. France Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share, 2017-2028
Figure 33. China Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2017-2028
Figure 37. India Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share, 2017-2028
Figure 39. By Country - South America Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share, 2017-2028
Figure 40. Brazil Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share, 2017-2028
Figure 44. Turkey Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2017-2028
Figure 48. Global Measles, Mumps and Rubella (MMR) Vaccines Production Capacity (K Doses), 2017-2028
Figure 49. The Percentage of Production Measles, Mumps and Rubella (MMR) Vaccines by Region, 2021 VS 2028
Figure 50. Measles, Mumps and Rubella (MMR) Vaccines Industry Value Chain
Figure 51. Marketing Channels
